Hair mousse

Phase 1Small molecule

DDuke University

Hair mousse is one of 2 small molecule programs targeting Breast Reconstruction. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Breast ReconstructionRecruiting

Breast ReconstructionPhase 1

Recruiting

Competition

Competitive Landscape

1 competitor in Breast Reconstruction

#DrugCompanyPhaseTrials

Rogaine

Pfizer

Phase 1

1 2

Hair mousse

DDuke University

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

Phase 1Recruiting

Breast Reconstruction

NCT07264790

Clinical

Trials by Indication[1]

Breast Reconstruction1 trial

Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Reconstruction

Recruiting·DDuke University·Phase 1·NCT07264790·25 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Hair mousse. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hair mousse compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hair mousse. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Duke University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: DDuke University

Hair mousse

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Breast Reconstruction1 trial

References

Drug Info

Quick Facts

Related News